Brief: Chordate Medical Holding Resumes Finnish Study Of Chronical Migraine
Feb 23 (Reuters) - Chordate Medical Holding publ AB
CMHM.NGM :
* RESUMES FINNISH STUDY OF CHRONICAL MIGRAINE
* STUDY, WHICH IS BEING CARRIED OUT AT NINE CLINICS IN
GERMANY AND
FINLAND, WAS SUSPENDED DUE TO THE COVID-19 PANDEMIC IN 2020
* THE ENTIRE STUDY IS EXPECTED TO BE COMPLETED AS PREVIOUSLY
COMMUNICATED BY THE SUMMER OF 2021
Source text for Eikon: ID:nBQN68d6bL
Further company coverage: CMHM.NGM
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln